Literature DB >> 9784566

Nitric oxide synthase expression in macrophages of Histoplasma capsulatum-infected mice is associated with splenocyte apoptosis and unresponsiveness.

B A Wu-Hsieh1, W Chen, H J Lee.   

Abstract

Splenic macrophages from Histoplasma capsulatum-infected mice express inducible nitric oxide synthase (iNOS), and the iNOS expression correlates with severity of the infection. We examined whether production of NO is responsible for apoptosis and the anti-lymphoproliferative response of splenocytes from mice infected with H. capsulatum. In situ terminal deoxynucleotidyl transferase nick end labeling revealed apoptotic nuclei in cryosections of spleen from infected but not normal mice. Splenocytes of infected mice were unresponsive to stimulation by either concanavalin A or heat-killed H. capsulatum yeast cells. Splenocyte responsiveness was restored by addition to the medium of NG-monomethyl-L-arginine, a known inhibitor of NO production. The proliferative response of splenocytes from infected mice was also restored by depletion of macrophages or by replacement with macrophages from normal mice. In addition, expression of iNOS returned to its basal level when the animals had recovered from infection. These results suggest that suppressor cell activity of macrophages is associated with production of NO, which also appears to be an effector molecule for apoptosis of cultured splenocytes from infected mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784566      PMCID: PMC108692     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells.

Authors:  R P Artz; W E Bullock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

2.  Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations.

Authors:  D A Nickerson; R A Havens; W E Bullock
Journal:  Cell Immunol       Date:  1981-05-15       Impact factor: 4.868

3.  Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum.

Authors:  B Wu-Hsieh
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

4.  Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway.

Authors:  C D Mills
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

5.  Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon.

Authors:  B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway.

Authors:  J E Albina; J A Abate; W L Henry
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

7.  Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection.

Authors:  J Sternberg; F McGuigan
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

8.  Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice.

Authors:  S R Watson; T B Miller; T J Redington; W E Bullock
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

10.  Properties of isolated red pulp macrophages from mouse spleen.

Authors:  A R Nusrat; S D Wright; A A Aderem; R M Steinman; Z A Cohn
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis.

Authors:  Jon P Woods
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

2.  TNF-alpha antagonism generates a population of antigen-specific CD4+CD25+ T cells that inhibit protective immunity in murine histoplasmosis.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

3.  Detrimental role of endogenous nitric oxide in host defence against Sporothrix schenckii.

Authors:  Karla Simone S Fernandes; Edward Helal Neto; Marcelly M S Brito; João S Silva; Fernando Q Cunha; Christina Barja-Fidalgo
Journal:  Immunology       Date:  2008-01-09       Impact factor: 7.397

4.  Inducible nitric oxide synthase response and associated cytokine gene expression in the spleen of mice infected with Clonorchis sinensis.

Authors:  Ji-Qing Shen; Qing-Li Yang; Yan Xue; Xiao-Bing Cheng; Zhi-Hua Jiang; Yi-Chao Yang; Ying-Dan Chen; Xiao-Nong Zhou
Journal:  Parasitol Res       Date:  2015-02-17       Impact factor: 2.289

5.  An Intracellular Arrangement of Histoplasma capsulatum Yeast-Aggregates Generates Nuclear Damage to the Cultured Murine Alveolar Macrophages.

Authors:  Nayla de Souza Pitangui; Janaina de Cássia Orlandi Sardi; Aline R Voltan; Claudia T Dos Santos; Julhiany de Fátima da Silva; Rosangela A M da Silva; Felipe O Souza; Christiane P Soares; Gabriela Rodríguez-Arellanes; Maria Lucia Taylor; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2016-01-11       Impact factor: 5.640

6.  Protective Effect of Galectin-1 during Histoplasma capsulatum Infection Is Associated with Prostaglandin E2 and Nitric Oxide Modulation.

Authors:  Lílian Cataldi Rodrigues; Adriana Secatto; Carlos A Sorgi; Naiara N Dejani; Alexandra I Medeiros; Morgana Kelly Borges Prado; Simone Gusmão Ramos; Richard D Cummings; Sean R Stowell; Lúcia Helena Faccioli; Marcelo Dias-Baruffi
Journal:  Mediators Inflamm       Date:  2016-09-06       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.